Finance

Lists
CVS:NYSE
CVS Health Corp
$ 86.46
+1.48%
(+1.26) 1D
$ 86.93
+0.55% (+0.47)
After hours
Closed: 10-р сарын 2, 16:00:08 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CVS...
Open
$ 85.25
High
$ 87.15
Low
$ 85.25
Mkt. cap
110.58Т
Avg. vol.
7.26 сая
Volume
10.46 сая
Dividend
3.08%
Quarterly dividend
$ 0.67
Ex-dividend date
2026 оны 4-р сарын 23
P/E ratio
22.92
52-wk high
$ 110.68
52-wk low
$ 69.51
EPS
$ 3.77
Beta
0.60
Shares outstanding
1.28 тэрбум
No. of employees
260 мян
Open
$ 85.25
High
$ 87.15
Low
$ 85.25
Mkt. cap
110.58Т
Avg. vol.
7.26 сая
Volume
10.46 сая
Dividend
3.08%
Quarterly dividend
$ 0.67
Ex-dividend date
2026 оны 4-р сарын 23
P/E ratio
22.92
52-wk high
$ 110.68
52-wk low
$ 69.51
EPS
$ 3.77
Beta
0.60
Shares outstanding
1.28 тэрбум
No. of employees
260 мян
News stories
From web sources and news partners
Profile
CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000. CVS started in Lowell, Massachusetts by brothers Stanley and Sidney Goldstein and their partner Ralph Hoagland. The name stood for Consumer Value Stores. Wikipedia
About CVS Health Corp
CEODavid Joyner
Employees260 мян
Founded1963
HeadquartersWoonsocket, Рөүд-Айленд, Америкийн Нэгдсэн Улс
SectorHealth care provider
Websitecvshealth.com
Analyst ratings
Based on 19 analysts giving stock ratings to CVS in the past 3 months
Strong buy
Buy
18
Hold
1
Sell
0
12-month forecast
Based on 19 Wall Street analysts offering 12 month price targets for CVS in the last 3 months.
Highest
Current $ 86.46
$ 125.00 (+44.58%)
Average
$ 114.37 (+32.28%)
Lowest
$ 103.00 (+19.13%)
Analyst
Recommendation
Action
Price target
Projected
Date
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
$ 125.00
+44.6%
10/02/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
$ 123.00
+42.3%
09/15/2026
Allen Lutz
Bank of America Securities
Buy
Maintained
$ 120.00
+38.8%
09/15/2026
Lance Wilkes
Bernstein
Buy
Reiterated
$ 106.00
+22.6%
09/09/2026
Kevin Caliendo
UBS
Buy
Reiterated
$ 118.00
+36.5%
09/03/2026
Brian Tanquilut
Jefferies
Buy
Maintained
$ 120.00
+38.8%
08/31/2026
Charles Rhyee
TD Cowen
Buy
Maintained
$ 110.00
+27.2%
08/26/2026
Jessica Tassan
Piper Sandler
Buy
Maintained
$ 113.00
+30.7%
08/26/2026
Steven Silver
Argus Research
Buy
Maintained
$ 114.00
+31.9%
08/18/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
$ 118.00
+36.5%
08/12/2026
Erin Wright
Morgan Stanley
Buy
Reiterated
$ 111.00
+28.4%
08/10/2026
Ben Hendrix
RBC Capital
Buy
Maintained
$ 113.00
+30.7%
08/06/2026
Michael Ha
Robert W. Baird
Buy
Maintained
$ 107.00
+23.8%
08/06/2026
David S Macdonald
Truist Financial
Buy
Reiterated
$ 118.00
+36.5%
08/06/2026
Andrew Mok CFA
Barclays
Buy
Maintained
$ 108.00
+24.9%
08/06/2026
Scott Fidel
Goldman Sachs
Buy
Maintained
$ 116.00
+34.2%
07/27/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
$ 120.00
+38.8%
07/13/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
$ 110.00
+27.2%
07/07/2026
Rajesh Kumar
HSBC
Hold
Maintained
$ 103.00
+19.1%
07/06/2026
George Hill
Deutsche Bank
Buy
Maintained
$ 92.00
+6.4%
05/07/2026
Courtney Breen
Bernstein
Buy
Maintained
$ 94.00
+8.7%
03/30/2026
Michael Cherny
Leerink Partners
Buy
Reiterated
$ 98.00
+13.3%
03/24/2026
Unknown Analyst
Oppenheimer
Hold
Reiterated
-
-
02/11/2026
Last report
2026 оны 8-р сарын 5
Fiscal period
Q2 2026
EPS / Est. (USD)
$ 2.58 / $ 1.85
+39.36%beat
Revenue / Est. (USD)
105.46Т / 100.09Т
+5.36%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
102.24Т
105.10Т
99.85 тэрбум
105.46Т
Cost of goods sold
89.06 тэрбум
92.13 тэрбум
84.80 тэрбум
90.35 тэрбум
Cost of revenue
89.06 тэрбум
92.13 тэрбум
84.80 тэрбум
90.35 тэрбум
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.86 тэрбум
11.32 тэрбум
10.93 тэрбум
11.04 тэрбум
Operating expense
10.86 тэрбум
11.32 тэрбум
10.93 тэрбум
11.04 тэрбум
Total operating expenses
99.92 тэрбум
103.45Т
95.73 тэрбум
101.38Т
Operating income
2.32 тэрбум
1.65 тэрбум
4.12 тэрбум
4.07 тэрбум
Other non operating income
26.00 сая
-88.00 сая
32.00 сая
31.00 сая
EBT including unusual items
-3.48 тэрбум
1.35 тэрбум
3.94 тэрбум
3.98 тэрбум
EBT excluding unusual items
2.19 тэрбум
1.37 тэрбум
3.95 тэрбум
3.99 тэрбум
Income tax expense
508.00 сая
-1.57 тэрбум
981.00 сая
982.00 сая
Effective tax rate
-14.59%
-115.88%
24.91%
24.69%
Other operating expenses
-
-
-
-
Net income
-3.98 тэрбум
2.94 тэрбум
2.94 тэрбум
2.98 тэрбум
Net profit margin
-3.89%
2.80%
2.95%
2.82%
Earnings per share
1.60
1.09
2.57
2.58
Interest and investment income
632.00 сая
594.00 сая
574.00 сая
641.00 сая
Interest expense
-784.00 сая
-787.00 сая
-774.00 сая
-757.00 сая
Net interest expenses
-152.00 сая
-193.00 сая
-200.00 сая
-116.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
3.45 тэрбум
2.80 тэрбум
5.23 тэрбум
5.20 тэрбум
Gain or loss from assets sale
-483.00 сая
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google аппс